BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 342309)

  • 1. Experience with monovalent and bivalent influenza vaccines in Canada 1976. Clinical evaluation of vaccines from four sources.
    Johnson SE; Pearson EW
    Dev Biol Stand; 1977 Jun 1-3; 39():267-72. PubMed ID: 342309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgM and IgG antibody responses following immunization of children and adults with influenza A/NJ/76 vaccines.
    Boyer KM; Cherry JD; Noble GR
    Dev Biol Stand; 1977 Jun 1-3; 39():303-8. PubMed ID: 604113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of an inhibitor-resistant live attenuated influenza vaccine in normal and asthmatic adults.
    Warshauer DM; Minor TE; Inhorn SL; Reed CE; Dick EC
    Dev Biol Stand; 1976; 33():184-90. PubMed ID: 782967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intradermal administration of bivalent and monovalent influenza vaccines.
    Brooks JH; Criep LH; Ruben FL
    Ann Allergy; 1977 Aug; 39(2):110-2. PubMed ID: 889154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human responses to purified surface antigen invluenza vaccine (Fluvirin).
    Stones PB; Furminger IG; Kerr J
    Dev Biol Stand; 1977 Jun 1-3; 39():239-42. PubMed ID: 604103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials with a new influenza subunit vaccine in adults and children.
    Kunz C; Hofmann H; Bachmayer H; Liehl E; Moritz AJ
    Dev Biol Stand; 1977 Jun 1-3; 39():297-302. PubMed ID: 342311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivated influenza A/New Jersey/76 vaccines in children: results of a mult-center trial.
    Wright PF; Vaughn WK; Thompson J; Sell SH; Karzon DT
    Dev Biol Stand; 1977 Jun 1-3; 39():309-13. PubMed ID: 342312
    [No Abstract]   [Full Text] [Related]  

  • 8. Further researches on live influenza virus vaccines.
    De Barbieri A; Crovari P; Cuneo-Crovari P; Giacometti G
    Dev Biol Stand; 1977 Jun 1-3; 39():73-6. PubMed ID: 604136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison between killed subunit influenza vaccines and whole virion preparations: study of reactions and protective efficacy in children and adults].
    Profeta ML; Bigatello A; Vacchini V; Bramati L; Ferrante P
    Boll Ist Sieroter Milan; 1980 Jan; 58(6):457-74. PubMed ID: 6778485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza surveillance of Wisconsin (USA) population-detection of A/New Jersey by isolation and serologic monitoring and vaccine evaluation.
    Nelson DB; Inhorn SL
    Dev Biol Stand; 1977 Jun 1-3; 39():429-36. PubMed ID: 342315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.
    Hehme N; Engelmann H; Kuenzel W; Neumeier E; Saenger R
    Virus Res; 2004 Jul; 103(1-2):163-71. PubMed ID: 15163505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological response to an adsorbed killed trivalent influenza vaccine (including A/New Jersey 8/76 antigen).
    Sarateanu D; Ehrengut W; Pressler K
    Dev Biol Stand; 1977 Jun 1-3; 39():235-8. PubMed ID: 604102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A placebo-controlled dose-response study of the reactogenicity and immunogenicity of a cold-adapted recombinant A/Victoria/3/75 (H3N2) live influenza virus candidate vaccine in healthy volunteers.
    Hrabar A; Vodopija I; André FE; Mitchell JR; Maassab HF; Hennessy AV; Davenport FM
    Dev Biol Stand; 1977 Jun 1-3; 39():53-60. PubMed ID: 342317
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children.
    Neuzil KM; Jackson LA; Nelson J; Klimov A; Cox N; Bridges CB; Dunn J; DeStefano F; Shay D
    J Infect Dis; 2006 Oct; 194(8):1032-9. PubMed ID: 16991077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response to anti-A/New Jersey/76 vaccines.
    Hannoun C; Barme M; Sérié C; Beck H; Aquino J; Thibon M
    Dev Biol Stand; 1977 Jun 1-3; 39():249-52. PubMed ID: 604105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical reactions to an adsorbed killed trivalent influenza vaccine (including A/New Jersey 8/76 antigen) with different immunization methods.
    Ehrengut W; Allerdist H; Erdmann G
    Dev Biol Stand; 1977 Jun 1-3; 39():283-7. PubMed ID: 342310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody response in humans after administration of whole-virion and split vaccine prepared from two different influenza A/swine viruses.
    Závadová H; Vonka V; Domorázková E; Syrůcek L; Stárek M; Hrusková J; Plesník V; Janout V; Uvízl M
    Dev Biol Stand; 1977 Jun 1-3; 39():231-4. PubMed ID: 604101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines.
    Hehme N; Engelmann H; Künzel W; Neumeier E; Sänger R
    Med Microbiol Immunol; 2002 Dec; 191(3-4):203-8. PubMed ID: 12458361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HI antibody response in volunteers vaccinated with live influenza A/New Jersey/76 vaccine.
    Ikić D; Smerdel S; Manhalter T; Pasini N; Delimar N
    Dev Biol Stand; 1977 Jun 1-3; 39():67-71. PubMed ID: 342319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials with inactivated monovalent (A/New Jersey/76) and bivalent (A/New Jersey/76-A/Victoria/75) influenza vaccines in Los Angeles children.
    Boyer KM; Cherry JD; Welliver RC; Deseda-Tous J; Zahradnik JM; Dudley JP; Krause PJ; Bryson YJ; Spencer MJ
    J Infect Dis; 1977 Dec; 136 Suppl():S661-4. PubMed ID: 342631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.